Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
about
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseasePsychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver diseaseThe first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.Psychotropic-induced weight gain and potential pharmacologic treatment strategies.Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College HospitalWeight gain, obesity, and psychotropic prescribing.Adolescent issues in epilepsy.Efficacy and safety of lamotrigine in pediatric patients.Update: new uses for lithium and anticonvulsants.Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.Review of lamotrigine and its clinical applications in epilepsy.Pregnancy, epilepsy, and anticonvulsants.New drugs for the treatment of epilepsy: a practical approachThe relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort studyAssociation of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid.Preventive treatment of migraine: effect on weight.Optimizing epilepsy management in teenagers.Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.Weight issues for people with epilepsy--a review.Valproic Acid and Hepatic Steatosis: A Possible Link? About a Case Report.Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial.The neuropathology of obesity: insights from human disease.Second-generation antiepileptic medications in children: efficacy and cognitive effects.Epilepsy, sex hormones and antiepileptic drugs in female patients.The Investigation of Insulin Resistance in Two Groups of Epileptic Patients Treated with Sodium Valproate and Carbamazepine.Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.Obesity and psychotropics.The long-term safety of antiepileptic drugs.Weight change, genetics and antiepileptic drugs.Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures.Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?A behavior-analytic conceptualization of the side effects of psychotropic medication.Predictors of ovulatory failure in women with epilepsy.Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia.
P2860
Q26798157-83E60D29-58B3-4BBF-927C-3EC505478770Q27012600-4278CAFD-507A-450D-B54C-AEF3980F7EB1Q33496263-7B6BB3EA-1C39-4492-85D4-4FD86FB14BEEQ33982437-FFEF0CB3-AB0C-4E31-A34B-507C230EF2FEQ34418639-61F35079-699B-49B1-ACF1-4A11A8B9D0A7Q34477637-75E3ED33-6436-434C-BA8D-14F3CFAB1EF2Q34557537-C0744E3E-0CEB-4D8C-97A6-05D21F59E4EBQ34599674-BC8DFE0B-49CA-45A3-959A-0E3AAA48584BQ34599692-E7BA7FF0-8636-4401-9317-EF20A4EED6FEQ34710521-048D3B00-7636-4A28-AA89-963BFEBEEE4EQ34745041-BE0B1E02-B90D-4F93-A563-DCF4F1096AEAQ34998063-6E27696F-BB0B-4CEF-88C7-7BB9A9A21990Q35058133-B8E02F80-C360-4BEA-A0A2-6C804AF34667Q35236942-D65E232D-5606-4C19-9125-295C4C655550Q35520425-F37189D7-674B-4C97-9C69-47918FB8D033Q35560405-25AD8026-BFC3-491F-8AC5-A049B19182F3Q35960111-4C50124A-F63A-4FFE-BEBB-FF0DC057637FQ35965897-9AA94230-40AF-4D9F-8B0B-46E781CCF99EQ35987931-1F77D656-D8F7-4A7E-A538-B789AEE434C8Q36561919-830D55C7-1F74-4AE7-BC65-71B2D8B3F5FEQ36662898-84194E7B-02A7-42DD-BF88-2109801EF49DQ36673011-42AD2EC7-A872-4638-B477-F0EDCF1743BCQ37019215-B7B2A0E8-47B9-468B-9F06-CEAE794ECF48Q37299861-CE318A43-5080-4FB6-84C5-C33ACF672C36Q37366007-4957CCC5-1F15-4552-82E8-FDB67C6FA2DBQ37432600-ECA257BF-5C2B-4DF5-B61E-737AF9F67B38Q37610152-BA111212-2070-4793-AE66-7987B31D89B3Q37642006-CE39ABD3-C0B9-4554-B8E7-11207D45D125Q37713560-179D5EA0-38CB-484D-B1EB-617767C5B81EQ37794213-3BE42A4B-1C7D-4A8B-ADDC-DEF63AC9185BQ37954390-4E0A61B3-1E4A-46B7-BF02-CB29CF5B879FQ38106856-76684865-1EAA-405B-A7CC-89F4F06976BCQ38168942-057A07E8-C8D4-43B3-A398-C516EA77F8BBQ38702913-6109814B-2FDF-4564-9795-91983C95A283Q38990303-17DE4B5B-C6F3-4CD5-97C3-C91E58E1997CQ40321741-4C30585F-3B00-4101-9612-B6CA3C9CAEE2Q41049740-04D0EC0A-2BE8-4624-80F1-F984FB13ED48Q42574706-3D2CDAEB-30DC-453C-8BCA-AF080B6816C3Q44226796-6E43114A-1B6F-4939-B7EC-113DEE7C1387Q44269727-CF6E86DA-94D4-46AD-AE8B-26CDE992658F
P2860
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Weight change associated with ...... apy in patients with epilepsy.
@ast
Weight change associated with ...... apy in patients with epilepsy.
@en
type
label
Weight change associated with ...... apy in patients with epilepsy.
@ast
Weight change associated with ...... apy in patients with epilepsy.
@en
prefLabel
Weight change associated with ...... apy in patients with epilepsy.
@ast
Weight change associated with ...... apy in patients with epilepsy.
@en
P2093
P356
P1433
P1476
Weight change associated with ...... apy in patients with epilepsy.
@en
P2093
P304
P356
10.1212/WNL.56.2.172
P407
P577
2001-01-01T00:00:00Z